Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Trial of Silymarin for Chronic Liver Diseases (SyNCH)
This study has been completed.
Study NCT00389376   Information provided by National Center for Complementary and Alternative Medicine (NCCAM)

First Received on October 16, 2006.   Last Updated on February 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis C
Non-Alcoholic Fatty Liver Disease
Additional conditions recognized in this trial
Fatty Liver
Hepatitis
Hepatitis A
Liver Diseases
More general conditions related to this trial
Digestive System Diseases
Enterovirus Infections
Flaviviridae Infections
Hepatitis, Viral, Human
Picornaviridae Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Placebo
Silymarin
More general drug interventions related to this trial
Antioxidants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sponsors listed in this trial
National Center for Complementary and Alternative Medicine (NCCAM)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services